Published in Clin Exp Immunol on June 01, 1999
Human malaria parasites in continuous culture. Science (1976) 59.70
Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol (1979) 23.90
Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry (1971) 21.72
Gamma-globulin and acquired immunity to human malaria. Nature (1961) 13.07
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg (1990) 4.70
Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum. J Exp Med (1984) 3.49
Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion. Proc Natl Acad Sci U S A (1984) 2.52
Research toward malaria vaccines. Science (1986) 2.40
Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria. Parasite Immunol (1986) 2.34
Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum. Nature (1986) 2.19
Structure of the RESA gene of Plasmodium falciparum. Nucleic Acids Res (1986) 1.92
The complete amino acid sequence of the human erythrocyte membrane anion-transport protein deduced from the cDNA sequence. Biochem J (1988) 1.87
Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunol Lett (1991) 1.73
Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components. Immunol Rev (1989) 1.73
Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion. Proc Natl Acad Sci U S A (1986) 1.51
Studies on the specificity of anti-erythrocyte antibodies in the serum of patients with malaria. Clin Exp Immunol (1983) 1.46
Immunoadsorbent isolation of antigens from the culture medium of in vitro cultivated Plasmodium falciparum. Acta Pathol Microbiol Scand C (1981) 1.43
Target antigens for asexual malaria vaccine development. Parasitol Today (1993) 1.22
T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA. J Immunol (1989) 1.21
Different malaria control activities in an area of Liberia--effects on malariometric parameters. Ann Trop Med Parasitol (1985) 1.19
A heat shock-like protein from the human malaria parasite Plasmodium falciparum induces autoantibodies. Eur J Immunol (1989) 1.17
Natural antibodies against three distinct and defined antigens of Plasmodium falciparum in residents of a mesoendemic area in Gabon. Am J Trop Med Hyg (1988) 1.12
T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine. Proc Natl Acad Sci U S A (1988) 1.03
Immune response to soluble exoantigens of Plasmodium falciparum may contribute to both pathogenesis and protection in clinical malaria: evidence from a longitudinal, prospective study of semi-immune African children. Eur J Immunol (1991) 1.02
Cloning and analysis of the RESA-2 gene: a DNA homologue of the ring-infected erythrocyte surface antigen gene of Plasmodium falciparum. Mol Biochem Parasitol (1992) 0.99
Involvement of Pf155/RESA and cross-reactive antigens in Plasmodium falciparum merozoite invasion in vitro. Infect Immun (1992) 0.97
Identification of T epitopes within a potential Plasmodium falciparum vaccine antigen. A study of human lymphocyte responses to repeat and nonrepeat regions of Pf155/RESA. J Immunol (1988) 0.97
Plasmodium falciparum reinfection in children from a holoendemic area in relation to seroreactivities against oligopeptides from different malaria antigens. Am J Trop Med Hyg (1991) 0.97
Failure of recombinant vaccinia viruses expressing Plasmodium falciparum antigens to protect Saimiri monkeys against malaria. Infect Immun (1991) 0.97
Passive immunization of Aotus monkeys with human antibodies to the Plasmodium falciparum antigen Pf155/RESA. Infect Immun (1991) 0.96
Antibodies to Plasmodium falciparum ring-infected erythrocyte surface antigen and P. falciparum and P. malariae circumsporozoite proteins: seasonal prevalence in Kenyan villages. Am J Trop Med Hyg (1989) 0.95
Antibodies to nonrepeat sequences of antigen Pf155/RESA of Plasmodium falciparum inhibit parasite growth in vitro. Parasitol Res (1998) 0.92
Immune responses to band 3 neoantigens on Plasmodium falciparum-infected erythrocytes in subjects living in an area of intense malaria transmission are associated with low parasite density and high hematocrit value. Infect Immun (1994) 0.91
The RESA-2 gene of Plasmodium falciparum is transcribed in several independent isolates. Infect Immun (1993) 0.90
The gene product of the Plasmodium falciparum 11.1 locus is a protein larger than one megadalton. Mol Biochem Parasitol (1991) 0.90
Antibodies to sequences in a non-repeat region of Plasmodium falciparum antigen Pf155/RESA inhibit either cytoadherence or parasite growth in vitro. Parasitology (1998) 0.88
Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum. Am J Trop Med Hyg (1991) 0.88
Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence. Parasite Immunol (1995) 0.87
A malariometric survey in a rural community in the Muheza district, Tanzania: age profiles in the development of humoral immune responses. Acta Trop (1997) 0.85
Development of malaria vaccines. Trop Geogr Med (1988) 0.83
High antibody responses in rabbits immunized with influenza virus ISCOMs containing a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA. Vaccine (1991) 0.80
T- and B-cell responses of malaria immune individuals to synthetic peptides corresponding to non-repeat sequences in the N-terminal region of the Plasmodium falciparum antigen Pf155/RESA. Acta Trop (1997) 0.79
Cytoadherence-related homologous motifs in Plasmodium falciparum antigen Pf155/RESA and erythrocyte band 3 protein. Parasitology (1995) 0.77
Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol (1972) 40.51
Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry (1971) 21.72
Cytotoxic effects of lymphoid cells in vitro. Adv Immunol (1969) 8.18
Contactual lysis of antibody-coated chicken erythrocytes by purified lymphocytes. Cell Immunol (1970) 5.10
Enzyme-linked immunosorbent assay. II. Quantitative assay of protein antigen, immunoglobulin G, by means of enzyme-labelled antigen and antibody-coated tubes. Biochim Biophys Acta (1971) 5.05
Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells. Transplant Rev (1972) 4.71
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet (2008) 4.35
Cytotoxic potential of stimulated human lymphocytes. J Exp Med (1967) 3.89
Quantitative studies on phytohaemagglutinin-induced cytotoxicity by human lymphocytes against homologous cells in tissue culture. Immunology (1967) 3.87
Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum. J Exp Med (1984) 3.49
The structure of postsynaptic densities isolated from dog cerebral cortex. I. Overall morphology and protein composition. J Cell Biol (1977) 2.98
Antigen from colon of germfree rats and antibodies in human ulcerative colitis. Ann N Y Acad Sci (1965) 2.72
Phytohaemagglutinin-induced cytotoxic action of unsensitized immunologically competent cells on allogeneic and xenogeneic tissue culture cells. Nature (1965) 2.69
Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion. Proc Natl Acad Sci U S A (1984) 2.52
Subcellular distribution in cerebral cortex of two proteins phosphorylated by a cAMP-dependent protein kinase. J Cell Biol (1979) 2.40
Plasmodium falciparum-infected erythrocytes form spontaneous erythrocyte rosettes. J Exp Med (1989) 2.34
Cytotoxic action of stimulated lymphocytes on allogenic and autologous erythrocytes. Science (1968) 2.17
Cytotoxic effects of leukocyres triggered by complement bound to target cells. Science (1969) 2.15
Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker. J Exp Med (1974) 2.13
Immunological studies in ulcerative colitis. 3. Incidence of antibodies to colon-antigen in ulcerative colitis and other gastro-intestinal diseases. Clin Exp Immunol (1966) 2.11
Immunological studies in ulcerative colitis. IV. Origin of autoantibodies. J Exp Med (1968) 2.02
Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity. J Exp Med (1981) 1.99
Cytoadherence of knobless Plasmodium falciparum-infected erythrocytes and its inhibition by a human monoclonal antibody. Nature (1989) 1.93
Local understanding, perceptions and reported practices of mothers/guardians and health workers on childhood malaria in a Tanzanian district--implications for malaria control. Acta Trop (2003) 1.87
Autoantibodies to colon in rats and human ulcerative colitis: cross reactivity with Escherichia coli O:14 antigen. Proc Soc Exp Biol Med (1967) 1.86
A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells. Cell Immunol (1978) 1.77
Presence of calmodulin in postsynaptic densities isolated from canine cerebral cortex. J Biol Chem (1979) 1.75
Specifically cytotoxic lymphocytes produced by preincubation with antibody-complexed target cells. J Immunol (1972) 1.74
Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components. Immunol Rev (1989) 1.73
Analysis by a plaque assay of IgG- or IgM- dependent cytolytic lymphocytes in human blood. J Exp Med (1976) 1.69
Cellular and humoral immune responses in experimental autoimmune thyroiditis. Int Arch Allergy Appl Immunol (1971) 1.65
Cellular and humoral immune responses to human urinary bladder carcinomas. Int J Cancer (1970) 1.64
Characterization of the humoral immune response in Plasmodium falciparum malaria. II. IgG subclass levels of anti-P. falciparum antibodies in different sera. Clin Exp Immunol (1983) 1.61
Inhibition of cytotoxicity of lymphocytes by concanavalin A in vitro. Science (1970) 1.59
Monoclonal antibody two-site ELISA for human IFN-gamma. Adaptation for determinations in human serum or plasma. J Immunol Methods (1989) 1.58
Impaired phytohaemagglutinin-induced cytotoxicity in vitro of lymphocytes from patients with Hodgkin's disease or chronic lymphatic leukaemia. Clin Exp Immunol (1967) 1.57
Thymus-dependent and thymus-independent effector functions of mouse lymphoid cells. Comparison of cytotoxicity and primary antibody formation in vitro. Cell Immunol (1973) 1.55
Characterization of the humoral immune response in Plasmodium falciparum malaria. I. Estimation of antibodies to P. falciparum or human erythrocytes by means of microELISA. Clin Exp Immunol (1983) 1.54
Regulation of the immune response in Plasmodium falciparum malaria. II. Antigen specific proliferative responses in vitro. Clin Exp Immunol (1983) 1.53
Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study. Int J Colorectal Dis (2006) 1.53
Transferrin can replace serum for in vitro growth of mitogen-stimulated T lymphocytes. Eur J Immunol (1979) 1.53
Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion. Proc Natl Acad Sci U S A (1986) 1.51
Production of IL 2 and IFN-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro. J Immunol (1985) 1.46
Studies on the specificity of anti-erythrocyte antibodies in the serum of patients with malaria. Clin Exp Immunol (1983) 1.46
Immune response to urinary bladder tumours in man. Int J Cancer (1970) 1.46
Serological diversity of antigens expressed on the surface of erythrocytes infected with Plasmodium falciparum. Trans R Soc Trop Med Hyg (1994) 1.45
IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria: association of high IgE levels with cerebral malaria. Clin Exp Immunol (1994) 1.44
Induction of aggregation and enhancement of proliferation and IL-2 secretion in human T cells by antibodies to CD43. J Immunol (1988) 1.41
Immunological studies in ulcerative colitis. II. "Colon" antigen and human blood group A- and H-like antigens in germfree rats. J Exp Med (1965) 1.41
Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens. Proc Natl Acad Sci U S A (1990) 1.40
Anti-Plasmodium falciparum antibodies acquired by residents in a holoendemic area of Liberia during development of clinical immunity. Am J Trop Med Hyg (1986) 1.40
Antibodies to a histidine-rich protein (PfHRP1) disrupt spontaneously formed Plasmodium falciparum erythrocyte rosettes. Proc Natl Acad Sci U S A (1990) 1.34
Limited genetic diversity of Plasmodium falciparum in field isolates from Honduras. Am J Trop Med Hyg (1999) 1.34
Antibody dependent cytolytic effector lymphocytes (K cells) in human blood. J Reticuloendothel Soc (1975) 1.33
The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. J Immunol (1989) 1.32
Regulation of the immune response in Plasmodium falciparum malaria. III. Proliferative response to antigen in vitro and subset composition of T cells from patients with acute infection or from immune donors. Clin Exp Immunol (1984) 1.32
Cytotoxicity of lymphocytes and its suppression. Antibiot Chemother (1969) 1.32
A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol Immunother (1985) 1.29
Cytolytic lymphocytic cells with complement receptor in human blood. Induction of cytolysis by IgG antibody but not by target cell-bound C3. J Exp Med (1975) 1.28
Purification, fractionation and assay of antibody-dependent lymphocytic effector cells (K cells) in human blood. Scand J Immunol (1976) 1.27
Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cells. Cell Immunol (1978) 1.27
Induction of cytotoxicity of lymphocytes from tolerant donors by antibodies to target cell alloantigens. Transplantation (1970) 1.26
Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: a prospective study in a malaria-endemic region of west Africa. Trans R Soc Trop Med Hyg (1992) 1.26
Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells? Lancet (1973) 1.26
Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells. J Immunol (1975) 1.25
Inhibition of cytotoxic lymphocytes by anti-lymphocytic serum. Transplant Proc (1969) 1.24
Immunochemistry of the common antigen of Enterobacteriaceae (Kunin). Relation to lipopolysaccharide core structure. J Exp Med (1971) 1.24
Immunological studies in ulcerative colitis. VII. Anti-colon antibodies of different immunoglobulin classes. Clin Exp Immunol (1970) 1.23
Morphological observations on the cytotoxicity of human bood lymphocytes for antibody-coated chicken erythrocytes. Exp Cell Res (1970) 1.22
Increased occurrence of cytoplasmic filaments in in vitro propagated rat liver epithelial cells. Exp Cell Res (1965) 1.22
Cell surface display of recombinant proteins on Staphylococcus carnosus. J Bacteriol (1995) 1.20
Study of Fab and F(ab') 2 from rabbit IgG for capacity to induce lymphocyte-mediated target cell destruction in vitro. Int Arch Allergy Appl Immunol (1972) 1.20
Why do Plasmodium falciparumm-infected erythrocytes form spontaneous erythrocyte rosettes? Parasitol Today (1989) 1.17
Severe malaria in Gambian children is not due to lack of previous exposure to malaria. Clin Exp Immunol (1992) 1.17
Fc gamma receptor IIa (CD32) polymorphism and antibody responses to asexual blood-stage antigens of Plasmodium falciparum malaria in Sudanese patients. Scand J Immunol (2007) 1.16
Receptors for Helix pomatia A haemagglutinin on leukaemic lymphocytes from patients with chronic lymphocytic leukaemia (CLL). Clin Exp Immunol (1976) 1.14
Distinct interethnic differences in immunoglobulin G class/subclass and immunoglobulin M antibody responses to malaria antigens but not in immunoglobulin G responses to nonmalarial antigens in sympatric tribes living in West Africa. Scand J Immunol (2005) 1.14
Induction of CD43 expression during activation and terminal differentiation of human B cells. Scand J Immunol (1988) 1.13
Enhancement or inhibition of Plasmodium falciparum erythrocyte reinvasion in vitro by antibodies to an asparagine rich protein. Mol Biochem Parasitol (1989) 1.12
Immunological studies in ulcerative colitis. V. Family studies. Gastroenterology (1971) 1.12
Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy. Int J Cancer (1972) 1.12
Cytotoxicity of human lymphocytes induced by rabbit antibodies to chicken erythrocytes. Inhibition by normal IgG and by human myeloma proteins of different IgG subclasses. Immunology (1973) 1.11
Genetic regulation of human anti-malarial antibodies in twins. Proc Natl Acad Sci U S A (1992) 1.11
Human monoclonal antibodies to Pf 155, a major antigen of malaria parasite Plasmodium falciparum. Science (1986) 1.11
Plasmodium falciparum: analysis of the cytoadherence inhibition of the human monoclonal antibody 33G2 and of antibodies reactive with antigen Pf332. Exp Parasitol (1993) 1.10
Regulation of the immune response in Plasmodium falciparum malaria. I. Non-specific proliferative responses in vitro and characterization of lymphocytes. Clin Exp Immunol (1983) 1.10
A dual expression system for the generation, analysis and purification of antibodies to a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA. J Immunol Methods (1989) 1.10